Carl Tobias

Carl Tobias News

  • J&J Gets $1.2 Billion Arkansas Risperdal Verdict Tossed

    Johnson & Johnson persuaded the Arkansas Supreme Court to throw out a $1.2 billion award against the drugmaker over its marketing of the antipsychotic drug Risperdal, erasing the biggest state verdict involving the controversial medicine.

  • BP Can Again Bid for U.S. Leases, Contracts After Spill

    BP Plc won the right to again compete for U.S. contracts and new leases in the Gulf of Mexico, where its massive 2010 oil spill prompted regulators to bar it from new government business.

  • GM Staff, Media Flagged Ignition Fault Long Before Recall

    General Motors Co.’s own engineers, along with newspaper auto writers, were talking about the ignition switch defect in several GM models almost a decade before the carmaker announced plans last month to recall 1.6 million vehicles.

  • Coloplast Said to Pay $16 Million to Settle Mesh Lawsuits

    Coloplast A/S, the Danish maker of medical products, agreed to pay about $16 million to settle lawsuits accusing it of injuring women with its vaginal-mesh inserts, three people familiar with the accord said.

  • Gay-Marriage Proponents Keep Win Streak as Appeals Loom

    A judge’s decision throwing out Virginia’s ban on gay marriage as a violation of the U.S. Constitution extends to seven the win streak for proponents of same-sex unions racing to get back to the U.S. Supreme Court.

  • Dow Loses $1.2 Billion Verdict as Top 2013 Award

    U.S. juries awarded three verdicts of $1 billion or more for the third straight year in 2013, topped by a $1.2 billion award against Dow Chemical Co., the largest ever in a price-fixing case.

  • Merck to Pay $100 Million NuvaRing Pact If Women Join

    Merck & Co. may pay $100 million to settle thousands of lawsuits over the safety of its NuvaRing contraceptive, a New Jersey judge held, as long as enough women agree to participate in the accord.

  • Merck Said to Agree to $100 Million NuvaRing Settlement

    Merck & Co. agreed to pay $100 million to settle several thousand lawsuits alleging the drugmaker’s NuvaRing contraceptive device causes potentially fatal blood clots, two people familiar with the accord said.

  • Glaxo Accord Said to Spur Lawyer Fight Over Fees

    GlaxoSmithKline Plc’s settlement of lawsuits over its Avandia drug triggered a challenge from nine law firms to a bid by lead attorneys for almost three-quarters of a $143 million fee fund, including one seeking about $2,700 per hour, according to two people familiar with the matter.

  • BP, Plaintiffs Seek Approval of $7.8 Billion Spill Accord

    BP Plc and the lead lawyers representing victims of the 2010 Gulf of Mexico oil spill urged a judge to approve a proposed $7.8 billion partial settlement of claims, while attorneys for thousands of plaintiffs sought rejection or modification of the agreement.

Sponsored Links
Curation software by Lingospot